BXN Stock Overview
Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products.
Bioxyne Limited Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||AU$0.023|
|52 Week High||AU$0.029|
|52 Week Low||AU$0.011|
|1 Month Change||-8.00%|
|3 Month Change||43.75%|
|1 Year Change||-17.86%|
|3 Year Change||64.29%|
|5 Year Change||-74.44%|
|Change since IPO||-87.90%|
Recent News & Updates
|BXN||AU Personal Products||AU Market|
Return vs Industry: BXN exceeded the Australian Personal Products industry which returned -41.9% over the past year.
Return vs Market: BXN underperformed the Australian Market which returned -4.1% over the past year.
|BXN Average Weekly Movement||21.6%|
|Personal Products Industry Average Movement||8.6%|
|Market Average Movement||8.9%|
|10% most volatile stocks in AU Market||15.9%|
|10% least volatile stocks in AU Market||4.1%|
Stable Share Price: BXN is more volatile than 90% of Australian stocks over the past 3 months, typically moving +/- 22% a week.
Volatility Over Time: BXN's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
Bioxyne Limited, a life sciences and health products company, researches, develops, markets, and distributes dietary supplement and beauty products. It perates in two segments, Wholesale Sales and Direct Sales. The company engages in developing various functional foods and beauty products.
Bioxyne Limited Fundamentals Summary
|BXN fundamental statistics|
Is BXN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|BXN income statement (TTM)|
|Cost of Revenue||AU$1.26m|
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.00035|
|Net Profit Margin||-9.52%|
How did BXN perform over the long term?See historical performance and comparison